Analysis of hematologic toxicity profiles following CAR-T cell therapy: a retrospective cohort study
This single-center retrospective cohort study included 96 consecutive patients with R/R B-cell malignancies treated with CAR T-cell therapy between November 2022 and March 2025 and aimed to characterize the incidence and predictors of N-ICAHT and T-ICAHT in a real-world cohort using the ICAHT and T-ICAHT grading framew...